Partnering with Big Pharma-What Academics Need to Know.

Lipton, Stuart A; Nordstedt, Christer

Lipton, Stuart A; Nordstedt, Christer.

Afiliação

Lipton SA; Scintillon Institute, San Diego, CA 92121, USA; The Scripps Research Institute, La Jolla, CA 92037, USA; School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: slipton@ucsd.edu.
Nordstedt C; Eli Lilly and Company, Indianapolis, IN 46285, USA.

Cell ; 165(3): 512-5, 2016 Apr 21.

Article em En | MEDLINE | ID: mdl-27104971

ABSTRACT

ABSTRACT

Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development-pharmacodynamics, pharmacokinetics, and toxicity studies-which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.

Assuntos

Sistemas de Liberação de Medicamentos; Desenho de Fármacos; Animais; Ensaios Clínicos como Assunto; Avaliação Pré-Clínica de Medicamentos; Humanos; Farmacocinética; Universidades

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Sistemas de Liberação de Medicamentos Limite: Animals / Humans Idioma: En Revista: Cell Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google